Medicover AB engages in the provision of invitro diagnostics and healthcare services. The company is headquartered in Stockholm, Stockholm and currently employs 49,000 full-time employees. The company went IPO on 2017-05-23. The company offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The firm offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The firm focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.
Mr. John Stubbington es el Chief Executive Officer de Medicover AB (publ), se unió a la empresa desde 2025.
¿Qué tal es el rendimiento del precio de la acción Medicover AB?
El precio actual de Medicover AB es de $16.55, ha disminuido un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Medicover AB (publ)?
Medicover AB (publ) pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Medicover AB (publ)?
La capitalización bursátil actual de Medicover AB (publ) es $1.2B
¿Es Medicover AB (publ) una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 8 analistas han realizado calificaciones de análisis para Medicover AB (publ), incluyendo 2 fuerte compra, 4 compra, 4 mantener, 0 venta, y 2 fuerte venta